Nath Bio-Genes

  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: INE448G01010
  • NSEID: NATHBIOGEN
  • BSEID: 537291
INR
133.05
-0.05 (-0.04%)
BSENSE

Nov 20

BSE+NSE Vol: 2.68 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 628630,
    "name": "Nath Bio-Genes",
    "stock_name": "Nath Bio-Genes",
    "full_name": "Nath Bio-Genes (India) Ltd",
    "name_url": "stocks-analysis/nath-bio-genes",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "133.05",
    "chg": -0.05,
    "chgp": "-0.04%",
    "dir": -1,
    "prev_price": "133.10",
    "mcapval": "253.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 537291,
    "symbol": "NATHBIOGEN",
    "ind_name": "Other Agricultural Products",
    "ind_code": 107,
    "indexname": "",
    "isin": "INE448G01010",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "2.68 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/nath-bio-genes-628630-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Nath Bio-Genes Falls 6.60% Amid Earnings Decline and Rising Interest Costs",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nath-bio-genes-falls-660-amid-earnings-decline-and-rising-interest-costs-4270712",
        "imagepath": "",
        "date": "2026-11-21 16:07:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 16:</strong> Sharp quarterly profit decline reported, signalling negative trend shift</p>\n                    <p><strong>Nov 16:</strong> MarketsMOJO upgrades rating from Strong Sell to Sell on technical improvement</p>\n                    <p><strong>Nov 20:</strong> Week closes at Rs.133.05, down 6.60% despite Sensex gains</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.142.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.133.05</div><div class=\"stat-change negative\">-6.60%<..."
      },
      {
        "title": "Nath Bio-Genes Reports Sharp Decline in Quarterly Financial Performance Amid Negative Trend Shift",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nath-bio-genes-reports-sharp-decline-in-quarterly-financial-performance-amid-negative-trend-shift-4264099",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NathBioGenesInd_fintrenddot_4264099.png",
        "date": "2026-11-16 13:00:31",
        "description": "Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has reported a marked deterioration in its financial trend for the quarter ended September 2026. The company’s financial trend score has plunged from a positive 5 to a negative -13 over the past three months, signalling a shift from stability to contraction in key performance metrics including revenue and profitability."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-strong-sell-4250428",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NathBioGenesInd_mojoScore_4250428.png",
        "date": "2026-11-04 10:11:29",
        "description": "Nath Bio-Genes (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 September 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 04 November 2026, providing investors with the latest perspective on the company’s performance and prospects."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-strong-sell-4236735",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/NathBioGenesInd_mojoScore_4236735.png",
        "date": "2026-10-24 10:10:39",
        "description": "Nath Bio-Genes (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 September 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 24 October 2026, providing investors with the latest comprehensive view of the company’s position."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-strong-sell-4224072",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/NathBioGenesInd_mojoScore_4224072.png",
        "date": "2026-10-13 10:10:56",
        "description": "Nath Bio-Genes (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 September 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 13 October 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-strong-sell-4211916",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/NathBioGenesInd_mojoScore_4211916.png",
        "date": "2026-10-02 10:10:44",
        "description": "Nath Bio-Genes (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 September 2026, reflecting a shift from the previous 'Sell' grade. However, all fundamentals, returns, and financial metrics discussed here are current as of 02 October 2026, providing investors with an up-to-date view of the stock's position."
      },
      {
        "title": "Nath Bio-Genes Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/nath-bio-genes-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-4199233",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/NathBioGenesInd_mojoScore_4199233.png",
        "date": "2026-09-21 08:11:54",
        "description": "Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 Sep 2026. This shift reflects deteriorating technical indicators, stagnant financial trends, weak quality metrics, and valuation concerns, signalling heightened caution for investors amid persistent underperformance against benchmarks."
      },
      {
        "title": "Nath Bio-Genes Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nath-bio-genes-forms-death-cross-signalling-potential-bearish-trend-4197719",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/NathBioGenesInd_dealthcross_4197719.png",
        "date": "2026-09-18 18:00:22",
        "description": "Nath Bio-Genes (India) Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and long-term weakness in the stock’s price action."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-4190468",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/NathBioGenesInd_mojoScore_4190468.png",
        "date": "2026-09-11 10:10:22",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 36,
    "sid": "628630",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/nath-bio-genes-india-628630"
  },
  "announcements": [
    {
      "caption": "Transcript",
      "datetime": "17-Nov-2026",
      "details": "Audio Transcript of Conference Call held on 16th November 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "16-Nov-2026",
      "details": "Presentation on Unaudited Financial Results as of 30th September 2026",
      "source": "BSE"
    },
    {
      "caption": "Financial Results - Outcome Of Board Meeting",
      "datetime": "14-Nov-2026",
      "details": "Unaudited Standalone and Consolidated Financial Results as on 30th September 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Nath Bio-Genes (India) Ltd has declared <strong>20%</strong> dividend, ex-date: 11 Sep 26",
          "dt": "2026-09-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Transcript

17-Nov-2026 | Source : BSE

Audio Transcript of Conference Call held on 16th November 2026

Announcement under Regulation 30 (LODR)-Investor Presentation

16-Nov-2026 | Source : BSE

Presentation on Unaudited Financial Results as of 30th September 2026

Financial Results - Outcome Of Board Meeting

14-Nov-2026 | Source : BSE

Unaudited Standalone and Consolidated Financial Results as on 30th September 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Nath Bio-Genes (India) Ltd has declared 20% dividend, ex-date: 11 Sep 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available